Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1972 3
1973 2
1975 2
1976 5
1977 2
1978 7
1979 4
1980 5
1981 2
1982 3
1983 5
1984 4
1985 3
1986 5
1987 5
1988 2
1989 8
1990 3
1991 5
1992 2
1993 6
1994 5
1995 7
1996 5
1997 6
1998 4
1999 3
2000 6
2001 2
2002 8
2003 5
2004 7
2005 8
2006 7
2007 4
2008 8
2009 13
2010 7
2011 18
2012 13
2013 8
2014 6
2015 18
2016 24
2017 15
2018 7
2019 15
2020 14
2021 23
2022 13
2023 12
2024 19
2025 21
2026 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
Low Back Pain: A Review.
Cashin AG, Chou R, Weimer MB, McAuley JH. Cashin AG, et al. JAMA. 2026 Jul 14;336(2):144-158. doi: 10.1001/jama.2026.9631. JAMA. 2026. PMID: 42295944 Review.
For patients with acute nonspecific low back pain, first-line therapies include heat application, spinal manipulation, massage, and acupuncture (typically provided by physical therapists, chiropractors, acupuncturists, and massage therapists) as well as nonsteroidal anti-inflamma …
For patients with acute nonspecific low back pain, first-line therapies include heat application, spinal manipulation, massage, and acupunct …
EULAR revised recommendations for the management of fibromyalgia.
Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. Macfarlane GJ, et al. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4. Ann Rheum Dis. 2017. PMID: 27377815 Free article. Review.
Temporomandibular Disorders: Rapid Evidence Review.
Matheson EM, Fermo JD, Blackwelder RS. Matheson EM, et al. Am Fam Physician. 2023 Jan;107(1):52-58. Am Fam Physician. 2023. PMID: 36689971 Free article. Review.
Pharmacologic therapy includes nonsteroidal anti-inflammatory drugs, cyclobenzaprine, tricyclic antidepressants, and gabapentin. Injections of the temporomandibular joints with sodium hyaluronate, platelet-rich plasma, and dextrose prolotherapy may be considered, but the e …
Pharmacologic therapy includes nonsteroidal anti-inflammatory drugs, cyclobenzaprine, tricyclic antidepressants, and gabapentin. Inje …
Choosing a skeletal muscle relaxant.
See S, Ginzburg R. See S, et al. Am Fam Physician. 2008 Aug 1;78(3):365-70. Am Fam Physician. 2008. PMID: 18711953 Free article. Review.
Comparison studies have not shown one skeletal muscle relaxant to be superior to another. Cyclobenzaprine is the most heavily studied and has been shown to be effective for various musculoskeletal conditions. The sedative properties of tizanidine and cyclobenzaprine …
Comparison studies have not shown one skeletal muscle relaxant to be superior to another. Cyclobenzaprine is the most heavily studied …
"Fibromyalgia - are there any new approaches?".
Martinez JE, Guimarães I. Martinez JE, et al. Best Pract Res Clin Rheumatol. 2024 Mar;38(1):101933. doi: 10.1016/j.berh.2024.101933. Epub 2024 Feb 13. Best Pract Res Clin Rheumatol. 2024. PMID: 38355316 Review.
Medications approved by Food and Drug Administration are duloxetine, milnacipran and pregabalin. Amitriptyline, cyclobenzaprine, gabapentin and naltrexone are considered for off-label use. Cannabinoids, vitamin D supplementation are still controversial and further research …
Medications approved by Food and Drug Administration are duloxetine, milnacipran and pregabalin. Amitriptyline, cyclobenzaprine, gaba …
Cyclobenzaprine.
[No authors listed] [No authors listed] 2017 Jan 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jan 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644201 Free Books & Documents. Review.
Cyclobenzaprine is a centrally acting muscle relaxant closely related to the tricyclic antidepressants. Despite its similarity to tricyclic antidepressants, there is little evidence that cyclobenzaprine causes liver injury....
Cyclobenzaprine is a centrally acting muscle relaxant closely related to the tricyclic antidepressants. Despite its similarity to tri …
Pharmacologic treatment of fibromyalgia: an update.
Li Y, Li Y, Wu S, Long M, Chen X, Wang Y, Zhao J, He B, Chang C, Jiao J. Li Y, et al. Front Pharmacol. 2025 Oct 10;16:1651181. doi: 10.3389/fphar.2025.1651181. eCollection 2025. Front Pharmacol. 2025. PMID: 41142233 Free PMC article. Review.
FDA approval, providing clinically meaningful relief in a minority of patients, and their frequent adverse events limit adherence. Numerous other agents, including cyclobenzaprine, gabapentinoids, NMDA antagonists, cannabinoids, and sodium oxybate, have been evaluated, but …
FDA approval, providing clinically meaningful relief in a minority of patients, and their frequent adverse events limit adherence. Numerous …
Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial.
Lederman S, Arnold LM, Vaughn B, Kelley M, Sullivan GM. Lederman S, et al. Arthritis Care Res (Hoboken). 2023 Nov;75(11):2359-2368. doi: 10.1002/acr.25142. Epub 2023 Jul 4. Arthritis Care Res (Hoboken). 2023. PMID: 37165930 Clinical Trial.
OBJECTIVE: To evaluate the efficacy and safety of TNX-102 SL, a once-nightly sublingual formulation of cyclobenzaprine, in reducing pain in patients with fibromyalgia (FM). METHODS: RELIEF was a double-blind, randomized, placebo-controlled trial. ...
OBJECTIVE: To evaluate the efficacy and safety of TNX-102 SL, a once-nightly sublingual formulation of cyclobenzaprine, in reducing p …
Cyclobenzaprine.
Khan I, Kahwaji CI. Khan I, et al. 2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 30020734 Free Books & Documents.
Cyclobenzaprine is a part of a group of medications referred to as cyclical antidepressants. ...In addition, this activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of cyclobenzaprine for members of th …
Cyclobenzaprine is a part of a group of medications referred to as cyclical antidepressants. ...In addition, this activity reviews th …
413 results